Results 91 to 100 of about 2,554,026 (187)
Treatment of Gout in Patients with CrCl ≤30 mL/min and/or on Hemodialysis: A Review
RheumatoGout is highly prevalent in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), owing to impaired uric acid excretion. However, treating gout in this population is challenging due to concerns about medication safety and ...
Fares Saliba +10 more
doaj +1 more source
Journal of the Pakistan Medical AssociationHyperuricaemia is highly prevalent in patients with chronic kidney disease (CKD), primarily due to reduced renal urate excretion. Elevated serum uric acid (SUA) levels have been linked with CKD progression, cardiovascular disease, and mortality. However,
Sourabh Sharma +3 more
doaj +1 more source
Impact of pegloticase on patient outcomes in refractory gout: current perspectives
Open Access Rheumatology: Research and Reviews, 2018 Rita N Cunha,1 Renata Aguiar,1 Filipa Farinha2 1Rheumatology Department, Centro Hospitalar do Baixo Vouga, Aveiro, Portugal; 2Centre for Rheumatology, University College London, London, UK Abstract: Gout is currently the most frequent cause of ...
Cunha RN, Aguiar R, Farinha F
doaj
Clinical Case ReportsA 58‐year‐old male with a history of gout presented with new‐onset neck pain. Dual‐energy CT revealed extensive urate crystal deposition in his cervical part and sternoclavicular joints, an uncommon manifestation.
Chenyang Zhang +3 more
doaj +1 more source
Moving urate-lowering therapy in gout beyond guideline recommendations
Seminars in Arthritis and RheumatismThe 'treat-to target serum urate strategy' when using urate-lowering therapy has been recommended by most specialist rheumatology societies for many years. An alternative "treat-to-avoid-symptoms" in gout has been suggested, albeit without a clear definition of what this means and how it might be implemented in clinical trials or clinical practice ...
Lisa K Stamp, Nicola Dalbeth
openaire +2 more sources
Cardiology JournalXanthine oxidase inhibitors, including allopurinol and febuxostat, are the first-line treatment of hyperuricemia. This meta-analysis investigated the association between urate-lowering therapy and all-cause mortality in different chronic diseases to ...
Marcin M. Nowak +3 more
doaj +1 more source
Lipid Lowering Therapy According to Clinical Outcomes in Elderly Population
, 2022 A systematic review of statin therapy and other lipid lowering agents and their efficacies in regard to the elderly population. In this review, I have introduced lipid metabolism and storage in the body.
Issa, Rabeh
core
, 2015 ACR: American College of Rheumatology; OR: odds ratio; CI: confidence interval; BSR: Brazilian Society of Rheumatology; CrCl: creatinine clearance. OR lower than 1 represents a reduced chance of concordance with the 2012 ACR gout guidelines.Multivariate ...
Geraldo da Rocha Castelar-Pinheiro (783431) +5 more
core +1 more source
Utility of the Morisky Medication Adherence Scale in gout: a prospective study
Patient Preference and Adherence, 2016 CSL Tan,1 GG Teng,1,2 KJ Chong,2 PP Cheung,1,2 AYN Lim,1,2 HL Wee,3,4 A Santosa1,2 1University Medicine Cluster, Division of Rheumatology, National University Health System, 2Department of Medicine, Yong Loo Lin School of Medicine, 3Department of ...
Tan CSL +6 more
doaj
Is Urate-lowering therapy a prevention of first gout episode? [PDF]
The growing problem of gout is beginning to raise questions about how we can effectively prevent this disease. This work examines the effect of urate-lowering therapy on preventing the onset of a first episode of gout—an effect that is not entirely clear,
Kulasza, Paulina Sara +9 more
core